Menu
Close
Global
×

Investor Relations

Information Disclosure
Announcements and Circulars Analyst Report Financial Reports Listing Documents
2025-11-20
DISCLOSEABLE TRANSACTIONS - REDEMPTIONS AND SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
2025-11-20
DISCLOSEABLE TRANSACTIONS - REDEMPTIONS AND SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
2025-11-18
ARTICLES OF ASSOCIATION
2025-11-18
ARTICLES OF ASSOCIATION
2025-11-17
AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2025-11-17
AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2025-11-07
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
2025-11-07
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
2025-11-06
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2025
2025-10-23
VOLUNTARY ANNOUNCEMENT - FIRST PATENT DOSED IN THE PHASE IB/II CLINICAL TRIAL OF IMM2510 IN COMBINATION WITH IMM01
2025-10-23
VOLUNTARY ANNOUNCEMENT - FIRST PATENT DOSED IN THE PHASE IB/II CLINICAL TRIAL OF IMM2510 IN COMBINATION WITH IMM01
2025-10-16
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE
2025-10-16
Next Day Disclosure Return
2025-10-16
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE
2025-10-09
PLACING OF NEW H SHARES UNDER GENERAL MANDATE
2025-10-09
PLACING OF NEW H SHARES UNDER GENERAL MANDATE
2025-10-08
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2025
2025-10-02
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR THE PHASE III CLINICAL TRIAL OF IMM2510
2025-10-02
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR THE PHASE III CLINICAL TRIAL OF IMM2510
2025-09-29
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR THE PHASE III CLINICAL TRIAL OF IMM0306 FOR THE TREATMENT OF FOLLICULAR LYMPHOMA
总计 218 1234567891011